ADVERTISEMENT FEATURE ADVERTISEMENT FEATURE

Animal Model Resource Rapid and Center, providing facilities for animal model development, accurate models phenotypic analysis, quality testing, species conservation, for human and reproduction. The centre supplies genetically diverse disease studies data resources, patient- derived xenografts, and 865 Researchers at the Institute of Laboratory animal models of both genetic Animal Sciences, Chinese Academy of and non-hereditary diseases, Medical Sciences & Peking Union Medical which include infectious, College, are improving RAPID AND cardiovascular, metabolic, ACCURATE MODEL DEVELOPMENT for and neural diseases, infectious and complex diseases. along with tumours and immunodeficiency. ILAS is also keen to As life sciences and researchers have quickly advance key technologies biomedical research cross developed humanized mice for animal model creation. new frontiers, the need for and monkey models. Their Its National Human Disease animal models is on the rise. studies have assisted with Chuan Qin, ILAS director Animal Model Technology Research into infectious understanding the mechanism Innovation Center takes and complex diseases is and routes of a comparative particularly driving the COVID-19, and developing candidates. In a Science paper risk for recovering COVID-19 protective coats. But the effort co-authored with collaborators and a member organization approach to develop demand for new models that relevant treatment and reporting the study on a patients. In a paper published is worth it, Qin says. “The from Switzerland and , of the International Council heterogeneous organs are stable and effective. The prevention strategies. purified inactivated in Science, they demonstrated best reward we get is the wide ILAS scientists detailed an for Laboratory Animal and antibodies based on outbreak of COVID-19 and the As ordinary mice cannot candidate that induced SARS- that monkeys reinfected with use of our animal models in artificial intelligence-powered Science, the Asian Federation humanized animal models, enormous research efforts to be infected with SARS- CoV-2–specific neutralizing the identical SARS-CoV-2 drug and vaccine evaluation brain-spinal cord interface, of Laboratory Animal supported by its phenotypic control it have sharpened this CoV-2, ILAS researchers set antibodies, researchers strain during early recovery studies.” which could enable upright Science Associations, and analysis and preclinical demand. out to genetically engineer showed that immunizations did not show any detectable walking for non-human the International Mouse translational technology Leading responses to these a transgenic mouse model of two vaccine doses clinical manifestations of the Advancing international primates, reducing gait Phenotyping Consortium. platforms. demands are researchers at that includes the humanized provided partial or complete viral disease or signs of viral collaboration abnormalities caused by spinal ILAS is also active in guiding The centre also has a the Institute of Laboratory ACE2 gene, which encodes protection against SARS- dissemination. Comparison Fighting the injuries. best practices in animal remit to incubate start-ups Animal Sciences (ILAS), part the receptor for SARS- CoV-2 in rhesus of cellular immunity between highlights the importance of For that study researchers research, particularly in ethical and talent, supporting drug of the Chinese Academy of CoV-2. Theirs was one of the macaque monkeys. ILAS’s primary infection and collaboration. One element developed rhesus monkey care of laboratory animals. development for major Medical Sciences. Started first of its kind available to animal model development reinfection revealed notably of ILAS’s success has models in which they In 2003, it established the diseases. 40 years ago to fill a national researchers. has supported evaluation of enhanced neutralizing been its establishment of implanted the brain-spine Institutional Animal Care Research resources and gap in laboratory animal ILAS scientists and their adenovirus vector, inactivated, antibody and immune collaborations with leading interface. Wireless control and Use Committee (IACUC) facilities aside, ILAS will studies, ILAS has developed collaborators have since used mRNA, DNA, attenuated, and responses for the latter, institutions worldwide, systems were designed to to push the implementation provide an open environment, into a leading hub for model that model to investigate the recombinant protein signalling potential protection through which, it has helped to decode the neural signals that of laboratory animal care with interdisciplinary development, teaching, pathogenesis of the virus. In for SARS-CoV-2, explains ILAS against reinfection. drive the fields of comparative govern leg movements and to regulations and guidelines, opportunities to researchers, resource supply and technical one study, published in Nature, director, Chuan Qin, who is a This important work was medicine and neuroscience. translate them into controlled and it was accredited by the complemented by generous services. Focusing on they observed virus replication lead author of the two studies. not easy. ILAS researchers Its exploration of animal movement of paralysed limbs Association for Assessment salaries and benefits. “We comparative medicine, ILAS in the lungs of infected mice, ILAS researchers also had to work in negative air models for nerve injury and using epidural electrical and Accreditation of expect talented scholars in life researchers work across along with weight loss. The used rhesus macaques to pressure cleanrooms for neurodegenerative diseases stimulation. The interface Laboratory Animal Care sciences and biomedicine will disciplines and diseases to study gave evidence that investigate the reinfection long hours, wearing heavy demonstrates its capacity allowed the monkeys to regain International in 2007. be keen to join our efforts of develop models for studies in SARS-CoV-2 is the pathogen for high-level international weight-bearing movements of promoting laboratory animal and beyond, including responsible for COVID-19, collaboration. the paralysed leg on treadmills Building laboratory animal sciences,” Qin says. SARS-CoV-2. while its pathogenicity To help patients with spinal or the ground, without prior study platforms appeared to be milder than cord-related paralysis, ILAS training. This implant has now One of the most lasting Addressing public that of SARS-CoV. researchers have, for instance, been approved for testing on contributions to science emergencies In addition to mouse worked with international humans for similar studies. by ILAS could be the When new diseases emerge, models, ILAS teams have neuroscience experts to Active in the international development of new research the rapid development of also created rhesus monkey explore brain-machine academic community, ILAS platforms to broadly enable accurate and useful models models for conducting safety interface (BMI) technologies is the chair organization of biomedical research of www.cnilas.org is vital. Responding to the and efficacy evaluations on ILAS researchers have developed mouse models for studies of SARS-CoV-2 and using animal models. the International Association all sorts. ILAS houses the [email protected] other diseases. 86-(0)10-67776050 SARS-CoV-2 demand, ILAS multiple drug and vaccine In a Nature paper in 2016, for Comparative Medicine, National Human Disease 86-(0)10-67776529

Advertiser retains sole responsibility for content Advertiser retains sole responsibility for content